Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies

Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies

Bibliographic Details
Main Authors:	Joseph R. Berger, Hans-Peter Hartung
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Neurology
Subjects:	progressive multifocal leucoencephalopathy (PML) multiple sclerosis natalizumab risk factors immunogenetics
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1146027/full

Similar Items

Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
by: Eli Hatchwell, et al.
Published: (2022-12-01)

Type O blood group associates with higher anti‐JC polyomavirus antibody levels
by: Pia Frenken, et al.
Published: (2021-08-01)

Progressive multifocal leukoencephalopathy as a complication of disease-modifying treatment of multiple sclerosis
by: Maria N. Zakharova, et al.
Published: (2018-12-01)

Switch to ocrelizumab in MS patients treated with natalizumab in extended interval dosing at high risk of PML: A 96-week follow-up pilot study
by: Pilar Santiago-Setien, et al.
Published: (2023-02-01)

Killing Two Birds With One Stone: Effective Control of Both Non-Small Cell Lung Cancer and Progressive Multifocal Leukoencephalopathy With Atezolizumab, A Case Report
by: Nicolas Lambert, et al.
Published: (2022-05-01)

Neuropsychological Disability in the Case of Natalizumab-Related Progressive Multifocal Leukoencephalopathy
by: Viviana Lo Buono, et al.
Published: (2022-04-01)

Progressive multifocal leukoencephalopathy in a patient with multiple myeloma: a case report and analysis of the FDA adverse event reporting system
by: Elise Jonasson, et al.
Published: (2023-05-01)

Prevention and therapy of JC polyomavirus-mediated progressive multifocal leukoencephalopathy – a realistic possibility?
by: Ivan Jelcic, et al.
Published: (2017-10-01)

Progressive Multifocal Leukoencephalopathy Associated to Multiple Sclerosis Therapies: Review of the literature
by: Ana-Maria Vladila, et al.
Published: (2015-12-01)

The importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathy
by: Aron eLukacher, et al.
Published: (2015-01-01)

Anxiety and Perception of Disease Control in Multiple Sclerosis Subjects Treated with Natalizumab
by: Francesco Corallo, et al.
Published: (2023-12-01)

Patient monitoring during treatment with natalizumab (ORP-24)
by: Zohreh Abna
Published: (2023-01-01)

Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient
by: Lea Krey, et al.
Published: (2019-05-01)

Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment
by: Carla Prezioso, et al.
Published: (2021-08-01)

Progressive multifocal leukoencephalopathy
by: Rosca Elena Cecilia, et al.
Published: (2008-12-01)

Comparison of qPCR with ddPCR for the Quantification of JC Polyomavirus in CSF from Patients with Progressive Multifocal Leukoencephalopathy
by: Nyater Ngouth, et al.
Published: (2022-06-01)

Natalizumab y Leucoencefalopatía Multifocal Progresiva: adecuación a las recomendaciones del Ministerio de Sanidad de España
by: A. Fernández Pérez, et al.
Published: (2014-04-01)

Natalizumab y Leucoencefalopatía Multifocal Progresiva: adecuación a las recomendaciones del Ministerio de Sanidad de España
by: A. Fernández Pérez, et al.
Published: (2014-04-01)

A human T-lymphotropic virus-1 carrier who developed progressive multifocal leukoencephalopathy following immunotherapy for sarcoidosis: a case report
by: Takashi Nagahori, et al.
Published: (2023-02-01)

AIDS-related progressive multifocal leukoencephalopathy
by: Carolina de Oliveira Abrão, et al.
Published: (2020-12-01)

Immune Reconstitution Inflammatory Syndrome with Recurrent Paradoxical Cerebellar HIV-Associated Progressive Multifocal Leukoencephalopathy
by: Paola Frattaroli, et al.
Published: (2021-06-01)

Changes in Brain Volumes Are Relevant during Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: Lessons from a Case Report
by: Roberto De Masi, et al.
Published: (2022-11-01)

Myoclonus as an unusual presentation of progressive multifocal leukoencephalopathy in a HIV positive patient
by: Lucian Chicea, et al.
Published: (2012-12-01)

Progressive multifocal leukoencephalopathy in non-HIV patient
by: Diego Rosseman Vieira, et al.

A Systematic Review and Meta-analysis on Safety and Effectiveness of Extended-interval Dosing of Natalizumab in Patients with Relapsing-remitting Multiple Sclerosis: Is There Any Value in The Cost of Treatment? (PP-08)
by: Taraneh Mousavi, et al.
Published: (2023-01-01)

HIV-Associated Progressive Multifocal Leukoencephalopathy: A Case Study
by: Elsayed Abed, et al.
Published: (2023-04-01)

Leucoencefalopatía multifocal progresiva asociada al uso de Natalizumab en un paciente con esclerosis múltiple. Primer caso en Latinoamérica. Hospital de San José - Bogotá 2013
by: Javier Darío Triana, et al.
Published: (2015-02-01)

Brain atrophy patterns in multiple sclerosis patients treated with natalizumab and its clinical correlates
by: Arwa Rekik, et al.
Published: (2022-05-01)

A case of progressive multifocal leukoencephalopathy in a post-kidney transplant patient with improvement after discontinuation of immunosuppressive drugs and combination therapy with mefloquine and mirtazapine
by: Neri Sone, et al.
Published: (2023-12-01)

Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy
by: Nicolas Lambert, et al.
Published: (2022-01-01)

Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment
by: Carla Prezioso, et al.
Published: (2022-01-01)

Progressive multifocal leukoencephalopathy in a lung transplant recipient
by: Jason Sakizadeh, et al.
Published: (2024-03-01)

An Elusive Target: Inhibitors of JC Polyomavirus Infection and Their Development as Therapeutics for the Treatment of Progressive Multifocal Leukoencephalopathy
by: Jacob Kaiserman, et al.
Published: (2023-05-01)

Progressive multifocal leukoencephalopathy selectively affecting Broca's and Wernicke's areas in an immunocompetent patient: A case report
by: Renaid B. Kim, BS, et al.
Published: (2023-03-01)

JC virus-induced progressive multifocal leukoencephalopathy in a presumably healthy patient
by: Xiang Wang, et al.
Published: (2022-12-01)

Progressive Multifocal Leukoencephalopathy Presenting with Bilateral Myoclonus: A Case Report
by: Andrea Di PIETRO, et al.
Published: (2020-12-01)

Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications
by: Aurora Zanghì, et al.
Published: (2022-08-01)

Progressive Multifocal Leukoencephalopathy after Three Consecutive Liver Transplantations
by: F Ozdemir, et al.
Published: (2015-07-01)

Progressive multifocal leukoencephalopathy in an HIV patient: A case report and literature review
by: Ting Lei, et al.
Published: (2023-08-01)

A Cerebellar Tremor in a Patient with Human Immunodeficiency Virus-1 Associated with Progressive Multifocal Leukoencephalopathy
by: Hee-Jin Kim, et al.
Published: (2009-10-01)